Evotec AG, through its U.S. subsidiary, has entered a multi-year compound management agreement with the Medicines for Malaria Venture (MMV) to support its Malaria and Pathogen Box initiatives aimed at transforming drug discovery efforts for malaria and other neglected diseases. Financial details were not disclosed.   Evotec will leverage its compound management services to support MMV’s efforts to establish, maintain and distribute research tools to the global malaria research community. E...